A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

被引:0
作者
Jeeyun Lee
Young-Hyuck Im
Eun Yoon Cho
Yong Sang Hong
Hyo Rak Lee
Hyo Song Kim
Mi-Jin Kim
Kwhanmien Kim
Won Ki Kang
Keunchil Park
Young Mog Shim
机构
[1] Sungkyunkwan University School of Medicine,Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center
[2] Sungkyunkwan University School of Medicine,Department of Pathology, Samsung Medical Center
[3] Sungkyunkwan University School of Medicine,Department of Thoracic Surgery, Samsung Medical Center
来源
Cancer Chemotherapy and Pharmacology | 2008年 / 62卷
关键词
Esophageal Cancer; Esophageal Squamous Cell Carcinoma; Capecitabine; Overall Response Rate; Thymidine Phosphorylase;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:77 / 84
页数:7
相关论文
共 112 条
[1]  
Devesa SS(1998)Changing patterns in the incidence of esophageal and gastric carcinoma in the United States Cancer 83 2049-2053
[2]  
Blot WJ(1999)The changing epidemiology of esophageal cancer Semin Oncol 26 2-8
[3]  
Fraumeni JF(1998)Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 1979-1984
[4]  
Blot WJ(2003)Cancer statistics, 2003 CA Cancer J Clin 53 5-26
[5]  
McLaughlin JK(1999)Chemotherapy in esophageal cancer Semin Oncol 26 12-20
[6]  
Kelsen DP(1997)Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer Eur J Cancer 33 1216-1220
[7]  
Ginsberg R(2001)Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer Drugs 61 2309-2326
[8]  
Pajak TF(2006)Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group Ann Oncol 17 29-34
[9]  
Sheahan DG(2005)Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy Br J Cancer 92 246-251
[10]  
Gunderson L(2004)Cisplatin and capecitabine as first-line therapy for advanced gastric or gastroesophageal junction adenocarcinoma J Clin Oncol 22 14s-1898